Open Beta
TREN
MetriLume
TREN

US marketsADPT

SEC-sourced researchBeta

ADPT

Adaptive Biotechnologies Corp

Company comparison ↗

Data passport

CIK
0001478320
Exchange
Nasdaq
Business activity
Biological Products, (No Diagnostic Substances) · SIC 2836
Financial inputs
6/6
Filing date
Oct 6, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 170,276,000.0000 USD; December 2024: 178,957,000.0000 USD; December 2025: 276,976,000.0000 USD277M USD0 USD0December 2023December 2024December 2025
ADPT · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023170,276,000.0000Feb 26, 2026
December 2024178,957,000.0000Feb 26, 2026
December 2025276,976,000.0000Feb 26, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025276,976,000.0000-59,499,000.0000-45,986,000.0000512,736,000.0000287,735,000.0000Feb 26, 2026
December 2024178,957,000.0000-159,492,000.0000-95,212,000.0000539,376,000.0000336,891,000.0000Feb 26, 2026
December 2023170,276,000.0000-225,250,000.0000-156,324,000.0000——Feb 26, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

54/100
Profitability7
Growth100
Balance sheet44
Cash generation17
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$276.98MJan 1, 2025 – Dec 31, 2025Feb 26, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$178.96MJan 1, 2024 – Dec 31, 2024Feb 26, 202610-K
Net incomeNetIncomeLoss-$59.5MJan 1, 2025 – Dec 31, 2025Feb 26, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$45.99MJan 1, 2025 – Dec 31, 2025Feb 26, 202610-K
Total assetsAssets$512.74MDec 31, 2025Feb 26, 202610-K
Total liabilitiesLiabilities$287.74MDec 31, 2025Feb 26, 202610-K

New filings

Explore methodology ↗